OrthoPediatrics Corp (KIDS)

OrthoPediatrics Corp experienced significant insider trading activity over the past ninety days, totaling twenty-three sell transactions valued at approximately $53.1 million. Major stakeholders, including David R. Pelizzon and Jennifer N. Pritzker, divested substantial holdings. These sales occurred amid a 36.7% stock price increase, following an earnings report that exceeded expectations by 8%.
Ticker: KIDS Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for OrthoPediatrics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Squadron Capital LLC Large shareholder
Transaction date
Sale
Price
292.34
Quantity 58,108 -9.9%
Value US$1,402,246
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Sale
Price
166.37
Quantity 50,066 -8.5%
Value US$2,323,855
3.2
Pelizzon David R Non-Executive Director Large shareholder
Transaction date
Sale
Price
365.75
Quantity 96,307 -11.1%
Value US$859,442
3.2
Pelizzon David R Non-Executive Director Large shareholder
Transaction date
Sale
Price
21.01
Quantity 302,369 -4.6%
Value US$6,352,773
3.3
Squadron Capital LLC Large shareholder
Transaction date
Sale
Price
23.35
Quantity 22,500 -0.3%
Value US$525,375
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Sale
Price
23.35
Quantity 22,500 -0.3%
Value US$525,375
3.2
Pelizzon David R Non-Executive Director Large shareholder
Transaction date
Sale
Price
23.35
Quantity 22,500 -0.3%
Value US$525,375
3.3
Squadron Capital LLC Large shareholder
Transaction date
Sale
Price
23.10
Quantity 10,131 -0.2%
Value US$234,026
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Sale
Price
23.10
Quantity 10,131 -0.2%
Value US$234,026
3.2
Pelizzon David R Non-Executive Director Large shareholder
Transaction date
Sale
Price
23.10
Quantity 10,131 -0.2%
Value US$234,026
3.3
Squadron Capital LLC Large shareholder
Transaction date
Sale
Price
23.04
Quantity 326,700 -4.8%
Value US$7,527,168
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Sale
Price
23.04
Quantity 326,700 -4.8%
Value US$7,527,168
3.2
Pelizzon David R Non-Executive Director Large shareholder
Transaction date
Sale
Price
23.04
Quantity 326,700 -4.8%
Value US$7,527,168
3.3
Squadron Capital LLC Large shareholder
Transaction date
Sale
Price
24.28
Quantity 18,000 -0.3%
Value US$437,040
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Sale
Price
24.28
Quantity 18,000 -0.3%
Value US$437,040
3.2
Pelizzon David R Non-Executive Director Large shareholder
Transaction date
Sale
Price
24.28
Quantity 18,000 -0.3%
Value US$437,040
3.3
Squadron Capital LLC Large shareholder
Transaction date
Sale
Price
24.74
Quantity 16,300 -0.2%
Value US$403,262
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Sale
Price
24.74
Quantity 16,300 -0.2%
Value US$403,262
3.2
Pelizzon David R Non-Executive Director Large shareholder
Transaction date
Sale
Price
24.74
Quantity 16,300 -0.2%
Value US$403,262
3.3
Squadron Capital LLC Large shareholder
Transaction date
Sale
Price
25.75
Quantity 4,000 -0.1%
Value US$103,000
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Sale
Price
25.75
Quantity 4,000 -0.1%
Value US$103,000
3.2
Pelizzon David R Non-Executive Director Large shareholder
Transaction date
Sale
Price
25.75
Quantity 4,000 -0.1%
Value US$103,000
3.3
Squadron Capital, LLC 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
26.23
Quantity 700,000
Value US$18,361,000
2.9
Hauser Joseph W Pres. Trauma & Def. Correction Officer
Transaction date
Sale
Price
17.25
Quantity 8,596 -4.2%
Value US$148,281
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
17.25
Quantity 12,993 -4.5%
Value US$224,129
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Sale
Price
17.25
Quantity 8,433 -4.3%
Value US$145,469
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
17.25
Quantity 19,535 -6.2%
Value US$336,979
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
17.25
Quantity 8,614 -5.4%
Value US$148,592
3.1
Odle Gregory A Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 8,433
Value US$145,506
2.2
Hite Fred Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 12,993
Value US$224,186
2.9
Hauser Joseph W Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 8,596
Value US$148,319
3.3
Gerritzen Daniel J Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 8,614
Value US$148,629
2.6
Bailey David R Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 19,535
Value US$337,065
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Purchase
Price
19.41
Quantity 5,076 +2.4%
Value US$98,525
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
24.86
Quantity 6,620 -2.0%
Value US$164,573
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
24.86
Quantity 5,310 -4.6%
Value US$132,007
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Sale
Price
24.86
Quantity 5,359 -3.5%
Value US$133,225
2.9
Hauser Joseph W Pres. Trauma & Def. Correction Officer
Transaction date
Sale
Price
24.86
Quantity 5,300 -3.7%
Value US$131,758
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
24.86
Quantity 6,443 -3.0%
Value US$160,173
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
29.30
Quantity 10,000 -11.5%
Value US$293,000
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
27.59
Quantity 3,195 -3.3%
Value US$88,150
2.5
Throdahl Mark C Non-Executive Director
Transaction date
Sale
Price
27.59
Quantity 2,433 -1.7%
Value US$67,126
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
27.59
Quantity 2,741 -5.0%
Value US$75,624
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Sale
Price
27.59
Quantity 2,768 -3.3%
Value US$76,369
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
27.59
Quantity 3,213 -2.3%
Value US$88,647
2.9
Hauser Joseph W Pres. Trauma & Def. Correction Officer
Transaction date
Sale
Price
28.06
Quantity 2,903 -5.2%
Value US$81,458
2.9
Schlotterback Terry D Non-Executive Director
Transaction date
Sale
Price
38.25
Quantity 2,610 -14.5%
Value US$99,832
2.9
Schlotterback Terry D Director Non-Executive Director
Transaction date
Proposed sale
Price
38.02
Quantity 2,610
Value US$99,238
2.2
Hite Fred Officer; Director, CFO & COO Executive Director
Transaction date
Proposed sale
Price
43.87
Quantity 4,356
Value US$191,098
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
43.69
Quantity 4,356 -4.3%
Value US$190,304
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Planned sale
Price
50.10
Quantity 3,333 -3.8%
Value US$166,969
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Planned sale
Price
50.02
Quantity 828 -0.9%
Value US$41,420
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Planned sale
Price
50.02
Quantity 644 -0.7%
Value US$32,212
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Sale
Price
44.03
Quantity 3,421 -4.8%
Value US$150,618
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
43.77
Quantity 4,099 -5.4%
Value US$179,397
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
44.62
Quantity 3,315 -8.5%
Value US$147,916
2.5
Throdahl Mark C Non-Executive Director
Transaction date
Sale
Price
43.83
Quantity 4,515 -3.4%
Value US$197,872
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
44.40
Quantity 4,052 -3.9%
Value US$179,910
2.9
Hauser Joseph W Sr VP & GM Trauma & Deformity Officer
Transaction date
Sale
Price
43.74
Quantity 2,554 -6.6%
Value US$111,705
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
50.00
Quantity 1,195 -1.6%
Value US$59,754
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
47.00
Quantity 80 -0.1%
Value US$3,760
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
45.00
Quantity 1,771 -2.4%
Value US$79,695
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
45.04
Quantity 229 -0.3%
Value US$10,315
3.6
Ruf Harold Non-Executive Director
Transaction date
Purchase
Price
39.45
Quantity 1,235 +9.8%
Value US$48,721
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
58.10
Quantity 4,078 -4.3%
Value US$236,932
2.5
Throdahl Mark C Non-Executive Director
Transaction date
Sale
Price
58.60
Quantity 5,961 -4.6%
Value US$349,315
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Sale
Price
57.55
Quantity 4,108 -6.1%
Value US$236,415
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
58.46
Quantity 3,918 -12.7%
Value US$229,046
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
57.48
Quantity 4,919 -7.5%
Value US$282,744
2.9
Hauser Joseph W Sr VP & GM Trauma & Deformity Officer
Transaction date
Sale
Price
46.04
Quantity 3,220 -10.8%
Value US$148,249
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
58.26
Quantity 500 +241.5%
Value US$29,130
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
60.36
Quantity 500 +62.5%
Value US$30,180
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
60.24
Quantity 500 +62.5%
Value US$30,120
3.2
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
60.42
Quantity 1,000 +10.1%
Value US$60,420
3.2
Pelizzon David R Non-Executive Director
Transaction date
Purchase
Price
66.48
Quantity 825 +3.7%
Value US$54,846
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-11 2026-09-10 S Sale Large shareholder
58,108 -9.9%
292.34
US$1,402,246
58,108 -9.9% 292.34 US$1,402,246
2026-09-11 2026-09-10 S Sale Large shareholder
50,066 -8.5%
166.37
US$2,323,855
50,066 -8.5% 166.37 US$2,323,855
2026-09-10 2026-09-10 S Sale Non-Executive Director Large shareholder
96,307 -11.1%
365.75
US$859,442
96,307 -11.1% 365.75 US$859,442
2026-09-10 2026-09-10 S Sale Non-Executive Director Large shareholder
302,369 -4.6%
21.01
US$6,352,773
302,369 -4.6% 21.01 US$6,352,773
2026-09-04 2026-09-02 S Sale Large shareholder
22,500 -0.3%
23.35
US$525,375
22,500 -0.3% 23.35 US$525,375
2026-09-04 2026-09-02 S Sale Large shareholder
22,500 -0.3%
23.35
US$525,375
22,500 -0.3% 23.35 US$525,375
2026-09-04 2026-09-02 S Sale Non-Executive Director Large shareholder
22,500 -0.3%
23.35
US$525,375
22,500 -0.3% 23.35 US$525,375
2026-09-01 2026-09-01 S Sale Large shareholder
10,131 -0.2%
23.10
US$234,026
10,131 -0.2% 23.10 US$234,026
2026-09-01 2026-09-01 S Sale Large shareholder
10,131 -0.2%
23.10
US$234,026
10,131 -0.2% 23.10 US$234,026
2026-09-01 2026-09-01 S Sale Non-Executive Director Large shareholder
10,131 -0.2%
23.10
US$234,026
10,131 -0.2% 23.10 US$234,026
2026-09-01 2026-08-28 S Sale Large shareholder
326,700 -4.8%
23.04
US$7,527,168
326,700 -4.8% 23.04 US$7,527,168
2026-09-01 2026-08-28 S Sale Large shareholder
326,700 -4.8%
23.04
US$7,527,168
326,700 -4.8% 23.04 US$7,527,168
2026-09-01 2026-08-28 S Sale Non-Executive Director Large shareholder
326,700 -4.8%
23.04
US$7,527,168
326,700 -4.8% 23.04 US$7,527,168
2026-08-26 2026-08-26 S Sale Large shareholder
18,000 -0.3%
24.28
US$437,040
18,000 -0.3% 24.28 US$437,040
2026-08-26 2026-08-26 S Sale Large shareholder
18,000 -0.3%
24.28
US$437,040
18,000 -0.3% 24.28 US$437,040
2026-08-26 2026-08-26 S Sale Non-Executive Director Large shareholder
18,000 -0.3%
24.28
US$437,040
18,000 -0.3% 24.28 US$437,040
2026-08-26 2026-08-25 S Sale Large shareholder
16,300 -0.2%
24.74
US$403,262
16,300 -0.2% 24.74 US$403,262
2026-08-26 2026-08-25 S Sale Large shareholder
16,300 -0.2%
24.74
US$403,262
16,300 -0.2% 24.74 US$403,262
2026-08-26 2026-08-25 S Sale Non-Executive Director Large shareholder
16,300 -0.2%
24.74
US$403,262
16,300 -0.2% 24.74 US$403,262
2026-08-26 2026-08-24 S Sale Large shareholder
4,000 -0.1%
25.75
US$103,000
4,000 -0.1% 25.75 US$103,000
2026-08-26 2026-08-24 S Sale Large shareholder
4,000 -0.1%
25.75
US$103,000
4,000 -0.1% 25.75 US$103,000
2026-08-26 2026-08-24 S Sale Non-Executive Director Large shareholder
4,000 -0.1%
25.75
US$103,000
4,000 -0.1% 25.75 US$103,000
2026-08-24 2026-08-24 PrS Proposed sale

10% Stockholder

Large shareholder
700,000
26.23
US$18,361,000
700,000 26.23 US$18,361,000
2026-03-17 2026-03-16 S Sale

Pres. Trauma & Def. Correction

Officer
8,596 -4.2%
17.25
US$148,281
8,596 -4.2% 17.25 US$148,281
2026-03-17 2026-03-16 S Sale

COO and CFO

Executive Director
12,993 -4.5%
17.25
US$224,129
12,993 -4.5% 17.25 US$224,129
2026-03-17 2026-03-16 S Sale

President of Scoliosis

Officer
8,433 -4.3%
17.25
US$145,469
8,433 -4.3% 17.25 US$145,469
2026-03-17 2026-03-16 S Sale

President and CEO

Executive Director
19,535 -6.2%
17.25
US$336,979
19,535 -6.2% 17.25 US$336,979
2026-03-17 2026-03-16 S Sale

General Counsel and Secretary

Officer
8,614 -5.4%
17.25
US$148,592
8,614 -5.4% 17.25 US$148,592
2026-03-16 2026-03-16 PrS Proposed sale

Officer

Officer
8,433
17.25
US$145,506
8,433 17.25 US$145,506
2026-03-16 2026-03-16 PrS Proposed sale

Officer

Officer
12,993
17.25
US$224,186
12,993 17.25 US$224,186
2026-03-16 2026-03-16 PrS Proposed sale

Officer

Officer
8,596
17.25
US$148,319
8,596 17.25 US$148,319
2026-03-16 2026-03-16 PrS Proposed sale

Officer

Officer
8,614
17.25
US$148,629
8,614 17.25 US$148,629
2026-03-16 2026-03-16 PrS Proposed sale

Officer

Officer
19,535
17.25
US$337,065
19,535 17.25 US$337,065
2025-08-25 2025-08-21 B Purchase

COO and CFO

Executive Director
5,076 +2.4%
19.41
US$98,525
5,076 +2.4% 19.41 US$98,525
2025-03-18 2025-03-18 S Sale

President and CEO

Executive Director
6,620 -2.0%
24.86
US$164,573
6,620 -2.0% 24.86 US$164,573
2025-03-18 2025-03-18 S Sale

General Counsel and Secretary

Officer
5,310 -4.6%
24.86
US$132,007
5,310 -4.6% 24.86 US$132,007
2025-03-18 2025-03-18 S Sale

President of Scoliosis

Officer
5,359 -3.5%
24.86
US$133,225
5,359 -3.5% 24.86 US$133,225
2025-03-18 2025-03-18 S Sale

Pres. Trauma & Def. Correction

Officer
5,300 -3.7%
24.86
US$131,758
5,300 -3.7% 24.86 US$131,758
2025-03-18 2025-03-18 S Sale

COO and CFO

Executive Director
6,443 -3.0%
24.86
US$160,173
6,443 -3.0% 24.86 US$160,173
2024-08-22 2024-08-21 S Sale

General Counsel and Secretary

Officer
10,000 -11.5%
29.30
US$293,000
10,000 -11.5% 29.30 US$293,000
2024-03-12 2024-03-11 S Sale

COO and CFO

Executive Director
3,195 -3.3%
27.59
US$88,150
3,195 -3.3% 27.59 US$88,150
2024-03-12 2024-03-11 S Sale Non-Executive Director
2,433 -1.7%
27.59
US$67,126
2,433 -1.7% 27.59 US$67,126
2024-03-12 2024-03-11 S Sale

General Counsel and Secretary

Officer
2,741 -5.0%
27.59
US$75,624
2,741 -5.0% 27.59 US$75,624
2024-03-12 2024-03-11 S Sale

President of Scoliosis

Officer
2,768 -3.3%
27.59
US$76,369
2,768 -3.3% 27.59 US$76,369
2024-03-12 2024-03-11 S Sale

President and CEO

Executive Director
3,213 -2.3%
27.59
US$88,647
3,213 -2.3% 27.59 US$88,647
2024-02-23 2024-02-22 S Sale

Pres. Trauma & Def. Correction

Officer
2,903 -5.2%
28.06
US$81,458
2,903 -5.2% 28.06 US$81,458
2023-08-14 2023-08-11 S Sale Non-Executive Director
2,610 -14.5%
38.25
US$99,832
2,610 -14.5% 38.25 US$99,832
2023-08-11 2023-08-11 PrS Proposed sale

Director

Non-Executive Director
2,610
38.02
US$99,238
2,610 38.02 US$99,238
2023-06-26 2023-06-26 PrS Proposed sale

Officer; Director, CFO & COO

Executive Director
4,356
43.87
US$191,098
4,356 43.87 US$191,098
2023-06-26 2023-06-26 S Sale

COO and CFO

Executive Director
4,356 -4.3%
43.69
US$190,304
4,356 -4.3% 43.69 US$190,304
2023-04-28 2023-04-27 PlS Planned sale

President of Scoliosis

Officer
3,333 -3.8%
50.10
US$166,969
3,333 -3.8% 50.10 US$166,969
2023-04-26 2023-04-25 PlS Planned sale

President of Scoliosis

Officer
828 -0.9%
50.02
US$41,420
828 -0.9% 50.02 US$41,420
2023-04-24 2023-04-21 PlS Planned sale

President of Scoliosis

Officer
644 -0.7%
50.02
US$32,212
644 -0.7% 50.02 US$32,212
2023-03-07 2023-03-06 S Sale

Executive Vice President

Officer
3,421 -4.8%
44.03
US$150,618
3,421 -4.8% 44.03 US$150,618
2023-03-07 2023-03-06 S Sale

COO and CFO

Executive Director
4,099 -5.4%
43.77
US$179,397
4,099 -5.4% 43.77 US$179,397
2023-03-07 2023-03-06 S Sale

General Counsel and Secretary

Officer
3,315 -8.5%
44.62
US$147,916
3,315 -8.5% 44.62 US$147,916
2023-03-07 2023-03-06 S Sale Non-Executive Director
4,515 -3.4%
43.83
US$197,872
4,515 -3.4% 43.83 US$197,872
2023-03-07 2023-03-06 S Sale

President and CEO

Executive Director
4,052 -3.9%
44.40
US$179,910
4,052 -3.9% 44.40 US$179,910
2023-03-06 2023-03-02 S Sale

Sr VP & GM Trauma & Deformity

Officer
2,554 -6.6%
43.74
US$111,705
2,554 -6.6% 43.74 US$111,705
2023-02-03 2023-02-02 PlS Planned sale

Executive Vice President

Officer
1,195 -1.6%
50.00
US$59,754
1,195 -1.6% 50.00 US$59,754
2023-01-24 2023-01-20 PlS Planned sale

Executive Vice President

Officer
80 -0.1%
47.00
US$3,760
80 -0.1% 47.00 US$3,760
2023-01-17 2023-01-13 PlS Planned sale

Executive Vice President

Officer
1,771 -2.4%
45.00
US$79,695
1,771 -2.4% 45.00 US$79,695
2023-01-10 2023-01-09 PlS Planned sale

Executive Vice President

Officer
229 -0.3%
45.04
US$10,315
229 -0.3% 45.04 US$10,315
2022-06-16 2022-06-16 B Purchase Non-Executive Director
1,235 +9.8%
39.45
US$48,721
1,235 +9.8% 39.45 US$48,721
2022-03-03 2022-03-02 S Sale

President and CEO

Executive Director
4,078 -4.3%
58.10
US$236,932
4,078 -4.3% 58.10 US$236,932
2022-03-03 2022-03-02 S Sale Non-Executive Director
5,961 -4.6%
58.60
US$349,315
5,961 -4.6% 58.60 US$349,315
2022-03-03 2022-03-02 S Sale

Executive Vice President

Officer
4,108 -6.1%
57.55
US$236,415
4,108 -6.1% 57.55 US$236,415
2022-03-03 2022-03-02 S Sale

General Counsel and Secretary

Officer
3,918 -12.7%
58.46
US$229,046
3,918 -12.7% 58.46 US$229,046
2022-03-03 2022-03-02 S Sale

COO and CFO

Executive Director
4,919 -7.5%
57.48
US$282,744
4,919 -7.5% 57.48 US$282,744
2022-03-03 2022-02-07 S Sale

Sr VP & GM Trauma & Deformity

Officer
3,220 -10.8%
46.04
US$148,249
3,220 -10.8% 46.04 US$148,249
2021-12-13 2021-12-10 B Purchase Large shareholder
500 +241.5%
58.26
US$29,130
500 +241.5% 58.26 US$29,130
2021-12-13 2021-12-09 B Purchase Large shareholder
500 +62.5%
60.36
US$30,180
500 +62.5% 60.36 US$30,180
2021-12-13 2021-12-09 B Purchase Large shareholder
500 +62.5%
60.24
US$30,120
500 +62.5% 60.24 US$30,120
2021-12-13 2021-12-09 B Purchase Large shareholder
1,000 +10.1%
60.42
US$60,420
1,000 +10.1% 60.42 US$60,420
2021-11-12 2021-11-11 B Purchase Non-Executive Director
825 +3.7%
66.48
US$54,846
825 +3.7% 66.48 US$54,846

See older OrthoPediatrics Corp insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock OrthoPediatrics Corp history with Plus

Billed monthly · Cancel anytime